These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36037486)

  • 1. Neural network process simulations support a distributed memory system and aid design of a novel computer adaptive digital memory test for preclinical and prodromal Alzheimer's disease.
    Stricker JL; Corriveau-Lecavalier N; Wiepert DA; Botha H; Jones DT; Stricker NH
    Neuropsychology; 2023 Sep; 37(6):698-715. PubMed ID: 36037486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionating the Rey Auditory Verbal Learning Test: Distinct roles of large-scale cortical networks in prodromal Alzheimer's disease.
    Putcha D; Brickhouse M; Wolk DA; Dickerson BC;
    Neuropsychologia; 2019 Jun; 129():83-92. PubMed ID: 30930301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    Goldstein FC; Loring DW; Thomas T; Saleh S; Hajjar I
    J Alzheimers Dis; 2019; 72(2):507-514. PubMed ID: 31594225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.
    Graves LV; Holden HM; Van Etten EJ; Delano-Wood L; Bondi MW; Salmon DP; Corey-Bloom J; Delis DC; Gilbert PE
    J Int Neuropsychol Soc; 2018 Sep; 24(8):833-841. PubMed ID: 30113280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Younan D; Petkus AJ; Widaman KF; Wang X; Casanova R; Espeland MA; Gatz M; Henderson VW; Manson JE; Rapp SR; Sachs BC; Serre ML; Gaussoin SA; Barnard R; Saldana S; Vizuete W; Beavers DP; Salinas JA; Chui HC; Resnick SM; Shumaker SA; Chen JC
    Brain; 2020 Jan; 143(1):289-302. PubMed ID: 31746986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials.
    Loewenstein DA; Curiel Cid RE; Kitaigorodsky M; Crocco EA; Zheng DD; Gorman KL
    J Prev Alzheimers Dis; 2021; 8(2):181-187. PubMed ID: 33569565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline.
    Bock JR; Hara J; Fortier D; Lee MD; Petersen RC; Shankle WR
    J Prev Alzheimers Dis; 2021; 8(2):123-126. PubMed ID: 33569557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal shape and asymmetry analysis by cascaded convolutional neural networks for Alzheimer's disease diagnosis.
    Li A; Li F; Elahifasaee F; Liu M; Zhang L;
    Brain Imaging Behav; 2021 Oct; 15(5):2330-2339. PubMed ID: 33398778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model architecture can transform catastrophic forgetting into positive transfer.
    Ruiz-Garcia M
    Sci Rep; 2022 Jun; 12(1):10736. PubMed ID: 35750768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease.
    Curiel Cid RE; Matias-Guiu JA; Loewenstein DA
    Neuropsychology; 2023 Sep; 37(6):661-672. PubMed ID: 36480378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition and consolidation of verbal learning and episodic memory as predictors of the conversion from mild cognitive impairment to probable Alzheimer's disease.
    López-Pérez J; García-Herranz S; Díaz-Mardomingo MDC
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023 Jul; 30(4):638-653. PubMed ID: 35475773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease.
    Baek MJ; Kim HJ; Kim S
    J Clin Exp Neuropsychol; 2012; 34(4):396-404. PubMed ID: 22263656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial position effects on list learning tasks in mild cognitive impairment and Alzheimer's disease.
    Weitzner DS; Calamia M
    Neuropsychology; 2020 May; 34(4):467-478. PubMed ID: 31999168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease.
    Vannini P; Amariglio R; Hanseeuw B; Johnson KA; McLaren DG; Chhatwal J; Pascual-Leone A; Rentz D; Sperling RA
    Neuropsychologia; 2017 May; 99():343-349. PubMed ID: 28385579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust norms for neuropsychological tests of verbal episodic memory in Australian women.
    Goodwill AM; Campbell S; Henderson VW; Gorelik A; Dennerstein L; McClung M; Szoeke C
    Neuropsychology; 2019 May; 33(4):581-595. PubMed ID: 30829514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implicit prototype learning in patients with memory deficit: Evidence from a study with Alzheimer's disease patients.
    Zabberoni S; Carlesimo GA; Perri R; Barban F; Caltagirone C; Zannino GD
    Neuropsychology; 2022 Jan; 36(1):75-85. PubMed ID: 34735166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.